iRECIST: Guidelines for Response Criteria for Use in Trials Testing Immunotherapeutics
The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(17)30074-8
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2017
Authors
Publisher
Elsevier BV